Practice Pearl 3 0/1
Caring for newly diagnosed patients with early stage melanoma requires a management plan, and it is important to understand the nuances involved with different melanoma subtypes. In this interactive module, you will learn how to develop an appropriate treatment strategy based on risk and become familiar with first-line treatment modalities based on disease subtype. You will also gain an understanding of the role of sentinel lymph node biopsy in patient prognosis.
The Practice Pearls are a series of easy-to-digest resources for busy GPs and other medical, nursing and allied professionals who are not specialised in the treatment of melanoma. They have a strong diagnostic and practical management emphasis to help you gain a better understanding of the disease.
Dr Alexander Varey
Plastic and Reconstructive Surgeon, Melanoma Institute Australia and Westmead Hospital | Clinical Senior Lecturer, The University of Sydney
A/Prof Jonathan Stretch AM
Surgical Oncologist and Deputy Medical Director, Melanoma Institute Australia | Associate Professor of Melanoma and Skin Oncology, The University of Sydney
A/Prof Robyn Saw
General Surgeon, Melanoma Institute Australia | Associate Professor in Surgery, The University of Sydney | Head of Department, Melanoma and Surgical Oncology, Royal Prince Alfred Hospital.
This activity has been RACGP Accredited for 1 Category 2 point.
1. Describe the role of sentinel lymph node biopsy in the prognosis of patients with melanoma.
2. Develop an appropriate melanoma treatment strategy based on risk stratification.
3. List the recommended first-line treatment modalities for early melanoma based on subtype.